• We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
Logo of embojLink to Publisher's site
EMBO J. Jan 1992; 11(1): 49–56.
PMCID: PMC556424

The 2.2 A resolution crystal structure of influenza B neuraminidase and its complex with sialic acid.

Abstract

Influenza virus neuraminidase catalyses the cleavage of terminal sialic acid, the viral receptor, from carbohydrate chains on glycoproteins and glycolipids. We present the crystal structure of the enzymatically active head of influenza B virus neuraminidase from the strain B/Beijing/1/87. The native structure has been refined to a crystallographic R-factor of 14.8% at 2.2 A resolution and its complex with sialic acid refined at 2.8 A resolution. The overall fold of the molecule is very similar to the already known structure of neuraminidase from influenza A virus, with which there is amino acid sequence homology of approximately 30%. Two calcium binding sites have been identified. One of them, previously undescribed, is located between the active site and a large surface antigenic loop. The calcium ion is octahedrally co-ordinated by five oxygen atoms from the protein and one water molecule. Sequence comparisons suggest that this calcium site should occur in all influenza A and B virus neuraminidases. Soaking of sialic acid into the crystals has enabled the mode of binding of the reaction product in the putative active site pocket to be revealed. All the large side groups of the sialic acid are equatorial and are specifically recognized by nine fully conserved active site residues. These in turn are stabilized by a second shell of 10 highly conserved residues principally by an extensive network of hydrogen bonds.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1.7M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Images in this article

Click on the image to see a larger version.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Air GM, Laver WG, Webster RG, Els MC, Luo M. Antibody recognition of the influenza virus neuraminidase. Cold Spring Harb Symp Quant Biol. 1989;54(Pt 1):247–255. [PubMed]
  • Air GM, Laver WG, Luo M, Stray SJ, Legrone G, Webster RG. Antigenic, sequence, and crystal variation in influenza B neuraminidase. Virology. 1990 Aug;177(2):578–587. [PubMed]
  • Air GM, Gibbs AJ, Laver WG, Webster RG. Evolutionary changes in influenza B are not primarily governed by antibody selection. Proc Natl Acad Sci U S A. 1990 May;87(10):3884–3888. [PMC free article] [PubMed]
  • Baker AT, Varghese JN, Laver WG, Air GM, Colman PM. Three-dimensional structure of neuraminidase of subtype N9 from an avian influenza virus. Proteins. 1987;2(2):111–117. [PubMed]
  • Baker NJ, Gandhi SS. Effect of Ca++ on the stability of influenza virus neuraminidase. Arch Virol. 1976;52(1-2):7–18. [PubMed]
  • Bossart PJ, Babu YS, Cook WJ, Air GM, Laver WG. Crystallization and preliminary X-ray analyses of two neuraminidases from influenza B virus strains B/Hong Kong/8/73 and B/Lee/40. J Biol Chem. 1988 May 5;263(13):6421–6423. [PubMed]
  • Burmeister WP, Daniels RS, Dayan S, Gagnon J, Cusack S, Ruigrok RW. Sequence and crystallization of influenza virus B/Beijing/1/87 neuraminidase. Virology. 1991 Jan;180(1):266–272. [PubMed]
  • Chong AK, Pegg MS, von Itzstein M. Influenza virus sialidase: effect of calcium on steady-state kinetic parameters. Biochim Biophys Acta. 1991 Mar 8;1077(1):65–71. [PubMed]
  • Colman PM, Varghese JN, Laver WG. Structure of the catalytic and antigenic sites in influenza virus neuraminidase. Nature. 1983 May 5;303(5912):41–44. [PubMed]
  • Colman PM, Laver WG, Varghese JN, Baker AT, Tulloch PA, Air GM, Webster RG. Three-dimensional structure of a complex of antibody with influenza virus neuraminidase. Nature. 326(6111):358–363. [PubMed]
  • Deshairs C, Kessler N, Aymard M, Quash GA. Catalytic properties of the A/H3N2 influenza neuraminidases: influence of antigenic variations. J Gen Virol. 1986 Mar;67(Pt 3):409–418. [PubMed]
  • Friebolin H, Brossmer R, Keilich G, Ziegler D, Supp M. 1H-NMR-Spektroskopischer Nachweis der N-Acetyl-alpha-D-neuraminsäure als primäres Spaltprodukt der Neuraminidasen. Hoppe Seylers Z Physiol Chem. 1980 May;361(5):697–702. [PubMed]
  • Jones TA, Thirup S. Using known substructures in protein model building and crystallography. EMBO J. 1986 Apr;5(4):819–822. [PMC free article] [PubMed]
  • Kabsch W, Sander C. Dictionary of protein secondary structure: pattern recognition of hydrogen-bonded and geometrical features. Biopolymers. 1983 Dec;22(12):2577–2637. [PubMed]
  • Lentz MR, Webster RG, Air GM. Site-directed mutation of the active site of influenza neuraminidase and implications for the catalytic mechanism. Biochemistry. 1987 Aug 25;26(17):5351–5358. [PubMed]
  • Lin YJ, Luo M, Laver WG, Air GM, Smith CD, Webster RG. New crystalline forms of neuraminidase of type B human influenza virus. J Mol Biol. 1990 Aug 5;214(3):639–640. [PubMed]
  • Palese P, Tobita K, Ueda M, Compans RW. Characterization of temperature sensitive influenza virus mutants defective in neuraminidase. Virology. 1974 Oct;61(2):397–410. [PubMed]
  • Quiocho FA. Carbohydrate-binding proteins: tertiary structures and protein-sugar interactions. Annu Rev Biochem. 1986;55:287–315. [PubMed]
  • Roggentin P, Rothe B, Lottspeich F, Schauer R. Cloning and sequencing of a Clostridium perfringens sialidase gene. FEBS Lett. 1988 Sep 26;238(1):31–34. [PubMed]
  • Rothe B, Roggentin P, Frank R, Blöcker H, Schauer R. Cloning, sequencing and expression of a sialidase gene from Clostridium sordellii G12. J Gen Microbiol. 1989 Nov;135(11):3087–3096. [PubMed]
  • Shaw MW, Lamb RA, Erickson BW, Briedis DJ, Choppin PW. Complete nucleotide sequence of the neuraminidase gene of influenza B virus. Proc Natl Acad Sci U S A. 1982 Nov;79(22):6817–6821. [PMC free article] [PubMed]
  • Tulip WR, Varghese JN, Webster RG, Air GM, Laver WG, Colman PM. Crystal structures of neuraminidase-antibody complexes. Cold Spring Harb Symp Quant Biol. 1989;54(Pt 1):257–263. [PubMed]
  • Varghese JN, Laver WG, Colman PM. Structure of the influenza virus glycoprotein antigen neuraminidase at 2.9 A resolution. Nature. 1983 May 5;303(5912):35–40. [PubMed]
  • Webster RG, Brown LE, Laver WG. Antigenic and biological characterization of influenza virus neuraminidase (N2) with monoclonal antibodies. Virology. 1984 May;135(1):30–42. [PubMed]
  • Wei X, Els MC, Webster RG, Air GM. Effects of site-specific mutation on structure and activity of influenza virus B/Lee/40 neuraminidase. Virology. 1987 Feb;156(2):253–258. [PubMed]
  • Weis W, Brown JH, Cusack S, Paulson JC, Skehel JJ, Wiley DC. Structure of the influenza virus haemagglutinin complexed with its receptor, sialic acid. Nature. 1988 Jun 2;333(6172):426–431. [PubMed]
  • Wright CS. 2.2 A resolution structure analysis of two refined N-acetylneuraminyl-lactose--wheat germ agglutinin isolectin complexes. J Mol Biol. 1990 Oct 20;215(4):635–651. [PubMed]

Articles from The EMBO Journal are provided here courtesy of The European Molecular Biology Organization

Formats:

Related citations in PubMed

See reviews...See all...

Cited by other articles in PMC

See all...

Links

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...